Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

385 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-04-30

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an multicenter study for preventive and therapeutic strategies for patients with head and neck cancer

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Tobacco Smoking and Alcohol Drinking and Treatment Outcomes Among Patients With Lung or Head and Neck Cancer

NCT05523583

Lung or Head and Neck Cancer

COMPLETED

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

NCT07186699

Lung Non-Small Cell Carcinoma

RECRUITING

Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients

NCT03642041

Newly Diagnosed Lung Cancer Smoking, Cigarette Survival +1 more

COMPLETED

Environment and Lung Cancer

NCT05119244

Cannabis Use

UNKNOWN NA

An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK

NCT06575439

Lung Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Continuing the chronic intoxication by either tobacco or alcohol after the initial diagnosis of a first lung or head and neck cancer significantly improves the risk of experiencing a second cancer, and largely affects the long term survival. Addiction intervention programs should be personalized according to the patient's profile, with the aim to develop more sustained intervention and monitoring in patients identified at higher risk of not spontaneously stopping harmful substance use. As of today, the trajectories of smoking and drinking habits and the risk factors for persisting smoking or drinking habits have been insufficiently explored among patients with a first lung or head and neck cancer.

The ALTAK study aims to depict the rate of tobacco smokers 12 months after the initial diagnosis of a first lung or head and neck cancer. The secondary objectives of the study are:

* to depict the rate of alcohol users 12 months after the initial diagnosis of a H\&N cancer
* to depict the rate of tobacco smokers at cancer diagnosis
* to depict the rate of alcohol users at cancer diagnosis
* to determine the social, motivational, psychiatric, tobacco-related, alcohol-related, and cannabis-related features associated with stopping tobacco in the year following the diagnosis of a first TARC.
* to determine the social, psychiatric, tobacco-related, alcohol-related, and cannabis-related features associated with stopping alcohol drinking in the year following the diagnosis of a first H\&N cancer

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Head and Neck Cancer Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

head and neck or lung cancer

patient with a first head and neck cancer or first lung cancer

physician assessment

Intervention Type BEHAVIORAL

* Socio-economic conditions and general features: educational level, professional status...
* Assessment of current and past use of tobacco: current smoking status reported by the patient; in lifelong non-smokers: previous history of passive smoking reported by the patient; breath carbon monoxide level; in past smokers: age of first cigarette, total reported duration of active smoking, breath carbon monoxide level...
* in current smokers: age of first tobacco use, total reported duration of active smoking; Fagerström Nicotine Dependence Test...
* Assessment of the current and past uses of alcohol: previous-year assessment using the CAGE questionnaire and the AUDIT Test; average weekly alcohol consumption over the last 12 months...
* Assessment of current use of cannabis using the Cannabis Abuse Screening Test
* Psychiatric assessment using the MINI 5.0

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

physician assessment

* Socio-economic conditions and general features: educational level, professional status...
* Assessment of current and past use of tobacco: current smoking status reported by the patient; in lifelong non-smokers: previous history of passive smoking reported by the patient; breath carbon monoxide level; in past smokers: age of first cigarette, total reported duration of active smoking, breath carbon monoxide level...
* in current smokers: age of first tobacco use, total reported duration of active smoking; Fagerström Nicotine Dependence Test...
* Assessment of the current and past uses of alcohol: previous-year assessment using the CAGE questionnaire and the AUDIT Test; average weekly alcohol consumption over the last 12 months...
* Assessment of current use of cannabis using the Cannabis Abuse Screening Test
* Psychiatric assessment using the MINI 5.0

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* first head and neck or lung cancer
* first support
* age ≥ 18
* patient covered by health insurance
* signed informed consent

Exclusion Criteria

* prior lung or head and neck cancer
* History of another cancer \<5 years, not evolutive and untreated at baseline (carcinoma of the cervix, or basal cell carcinoma of the skin properly treated are allowed). The presence of a second discovery tumor location at the same time as the lung or head and neck cancer, is not a criteria for non-inclusion
* mesothelioma and oesophageal cancer
* unable to undergo trail medical follow up (geographical, social and psychological reasons)
* pregnant or nursing women
* patient under guardianship

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No